Supplementary Figures 1 - 6, Table 1 from &lt;i&gt;EGFR&lt;/i&gt; Kinase Domain Duplication (&lt;i&gt;EGFR&lt;/i&gt;-KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to Afatinib